SCHEMBL7092301

SCHEMBL7092301

O=C(CN1CCCNCC1)Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.50
CHEK1 O14757 7/20 0.49
CDK2 P24941 3/20 0.47
KIT P10721 3/20 0.47
CCNE2 O96020 2/20 0.47
CCNE1 P24864 2/20 0.47
FLT1 P17948 2/20 0.47
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
CDK1 P06493 1/20 0.46
PDGFRB P09619 1/20 0.45
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
TGFBR1 P36897 1/20 0.42
LCK P06239 1/20 0.42
CSF1R P07333 1/20 0.42
FLT3 P36888 1/20 0.42
TEK Q02763 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998835 0.96 KDR (0.53) KDRCHEK1CDK2KITCCNE2
SCHEMBL6999383 0.92 KDR (0.54) KDRCHEK1CDK2KITCCNE2
SCHEMBL6996857 0.88 KDR (0.61) KDRCHEK1CDK2KITCCNE2
SCHEMBL7000955 0.88 KDR (0.65) KDRCHEK1CDK2KITCCNE2
SCHEMBL7095976 0.86 CHEK1 (0.55) KDRCHEK1CDK2KITCCNE2
SCHEMBL7093948 0.85 CHEK1 (0.56) KDRCHEK1CDK2KITCCNE2
SCHEMBL7002932 0.81 CHEK1 (0.58) KDRCHEK1KITFLT1PDGFRB
SCHEMBL7004215 0.81 CHEK1 (0.57) KDRCHEK1KITFLT1PDGFRB
SCHEMBL7092358 0.81 CHEK1 (0.52) KDRCHEK1CDK2CDK1
SCHEMBL7094049 0.80 CHEK1 (0.60) KDRCHEK1CDK2CDK1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed